These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2884124)

  • 41. Influence of dynorphin A (1-13) and dynorphin A (1-10) amide on stress-induced analgesia.
    Starec M; Rosina J; Málek J; Krsiak M
    Physiol Res; 1996; 45(6):433-8. PubMed ID: 9085373
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiovascular effects of dynorphin A (1-13) in conscious rats and its modulation of morphine bradycardia over time.
    Glatt CE; Kenner JR; Long JB; Holaday JW
    Peptides; 1987; 8(6):1089-92. PubMed ID: 2894646
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intrathecal dynorphin(1-13) results in an irreversible loss of the tail-flick reflex in rats.
    Caudle RM; Isaac L
    Brain Res; 1987 Dec; 435(1-2):1-6. PubMed ID: 2892573
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Morphine and dynorphin(1-13) microinjected into the medial preoptic area and nucleus accumbens: effects on sexual behavior in male rats.
    Band LC; Hull EM
    Brain Res; 1990 Jul; 524(1):77-84. PubMed ID: 1976031
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparative study of monoaminergic involvement in the antinociceptive action of E-2078, morphine and U-50,488E.
    Nakazawa T; Yamanishi Y; Kaneko T
    J Pharmacol Exp Ther; 1991 May; 257(2):748-53. PubMed ID: 1674534
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Spinal antagonism of tolerance and dependence induced by systemically administered morphine.
    Delander GE; Takemori AE
    Eur J Pharmacol; 1983 Oct; 94(1-2):35-42. PubMed ID: 6686142
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. I. Injection procedures modify pharmacological responses.
    Long JB; Mobley WC; Holaday JW
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1158-66. PubMed ID: 2901486
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antinociceptive interactions between alpha 2-adrenergic and opiate agonists at the spinal level in rodents.
    Ossipov MH; Suarez LJ; Spaulding TC
    Anesth Analg; 1989 Mar; 68(3):194-200. PubMed ID: 2537587
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The endogenous kappa agonist, dynorphin(1-13), does not alter basal or morphine-stimulated dopamine metabolism in the nigrostriatal pathway of the rat.
    Wood PL; Kim HS; Cosi C; Iyengar S
    Neuropharmacology; 1987 Nov; 26(11):1585-8. PubMed ID: 2893309
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intrathecal administration of dynorphin A and its fragments increase heart rate and arterial pressure in the urethane anesthetized rat: mediation by a nonopioid mechanism.
    Rochford J; Godin C; Henry JL
    Brain Res; 1991 Nov; 565(1):67-77. PubMed ID: 1685349
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Non-dopaminergic mechanisms in the turning behavior evoked by intranigral opiates.
    Morelli M; Di Chiara G
    Brain Res; 1985 Aug; 341(2):350-9. PubMed ID: 2864100
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dynorphin: potent analgesic effect in spinal cord of the rat.
    Han JS; Xie CW
    Life Sci; 1982 Oct 18-25; 31(16-17):1781-4. PubMed ID: 6130439
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dynorphin-(1-13) is a potent in vivo suppressor of vasopressin levels in the rat.
    Haaf JA; Maigret C; Andringa-Bakker EA; van Wimersma Greidanus TB
    Acta Endocrinol (Copenh); 1987 Jan; 114(1):96-101. PubMed ID: 2880444
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The antinociceptive activity of intrathecally administered amiloride and its interactions with morphine and clonidine in rats.
    Ouyang H; Bai X; Huang W; Chen D; Dohi S; Zeng W
    J Pain; 2012 Jan; 13(1):41-8. PubMed ID: 22154330
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Involvement of dynorphin A and not substance P in the spinal antianalgesic action of capsaicin against morphine-induced antinociception in mice.
    Arts KS; Fujimoto JM; Tseng LF
    J Pharmacol Exp Ther; 1992 May; 261(2):643-51. PubMed ID: 1374471
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Substance P N-terminal fragment SP(1-7) attenuates chronic morphine tolerance and affects dynorphin B and nociceptin in rats.
    Zhou Q; Carlsson A; Hallberg M; Nyberg F
    Peptides; 2011 Aug; 32(8):1661-5. PubMed ID: 21763376
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prostaglandin E2 release evoked by intrathecal dynorphin is dependent on spinal p38 mitogen activated protein kinase.
    Svensson CI; Hua XY; Powell HC; Lai J; Porreca F; Yaksh TL
    Neuropeptides; 2005 Oct; 39(5):485-94. PubMed ID: 16176831
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Spinal involvement of both dynorphin A and Met-enkephalin in the antinociception induced by intracerebroventricularly administered bremazocine but not morphine in the mouse.
    Tseng LF; Collins KA
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1430-8. PubMed ID: 8103794
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
    Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intrathecal dynorphin A1-13 and dynorphin A3-13 reduce rat spinal cord blood flow by non-opioid mechanisms.
    Long JB; Kinney RC; Malcolm DS; Graeber GM; Holaday JW
    Brain Res; 1987 Dec; 436(2):374-9. PubMed ID: 2893653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.